These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 18424888)
21. [Correlation of E-cadherin hypermethylation to tumorigenesis and development of gastric cancer]. Liu WT; Jiao HL; Yang YL; Wang D; Zhang WM Ai Zheng; 2007 Nov; 26(11):1199-203. PubMed ID: 17991318 [TBL] [Abstract][Full Text] [Related]
22. Prognostic role of estrogen receptor alpha and estrogen receptor beta in gastric cancer. Xu CY; Guo JL; Jiang ZN; Xie SD; Shen JG; Shen JY; Wang LB Ann Surg Oncol; 2010 Sep; 17(9):2503-9. PubMed ID: 20339947 [TBL] [Abstract][Full Text] [Related]
23. Cathepsin B on invasion and metastasis of gastric carcinoma. Liu Y; Xiao S; Shi Y; Wang L; Ren W; Sloane BF Chin Med J (Engl); 1998 Sep; 111(9):784-8. PubMed ID: 11155666 [TBL] [Abstract][Full Text] [Related]
24. Overexpression of the mitotic checkpoint genes BUB1, BUBR1, and BUB3 in gastric cancer--association with tumour cell proliferation. Grabsch H; Takeno S; Parsons WJ; Pomjanski N; Boecking A; Gabbert HE; Mueller W J Pathol; 2003 May; 200(1):16-22. PubMed ID: 12692836 [TBL] [Abstract][Full Text] [Related]
25. Paradoxical expression of maspin in gastric carcinomas: correlation with carcinogenesis and progression. Yu M; Zheng H; Tsuneyama K; Takahashi H; Nomoto K; Xu H; Takano Y Hum Pathol; 2007 Aug; 38(8):1248-55. PubMed ID: 17490717 [TBL] [Abstract][Full Text] [Related]
26. Overexpression of IFITM1 has clinicopathologic effects on gastric cancer and is regulated by an epigenetic mechanism. Lee J; Goh SH; Song N; Hwang JA; Nam S; Choi IJ; Shin A; Kim IH; Ju MH; Jeong JS; Lee YS Am J Pathol; 2012 Jul; 181(1):43-52. PubMed ID: 22609115 [TBL] [Abstract][Full Text] [Related]
27. Inactivation of the Gastrokine 1 gene in gastric adenomas and carcinomas. Yoon JH; Song JH; Zhang C; Jin M; Kang YH; Nam SW; Lee JY; Park WS J Pathol; 2011 Apr; 223(5):618-25. PubMed ID: 21341273 [TBL] [Abstract][Full Text] [Related]
28. Preferential overexpression of CD44v5 in advanced gastric carcinoma Goseki grades I and III. Stachura J; Krzeszowiak A; Popiela T; Urbańczyk K; Pituch-Noworolska A; Wieckiewicz J; Zembala M Pol J Pathol; 1999; 50(3):155-61. PubMed ID: 10624117 [TBL] [Abstract][Full Text] [Related]
29. The role of Reg IV gene and its encoding product in gastric carcinogenesis. Zheng HC; Xu XY; Yu M; Takahashi H; Masuda S; Takano Y Hum Pathol; 2010 Jan; 41(1):59-69. PubMed ID: 19740514 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of cyclin D1 mRNA expression in gastric and colorectal cancers. Oda K; Okabayashi T; Kataoka M; Takeda A; Shibuya Y; Orita K; Tanaka N Res Commun Mol Pathol Pharmacol; 1999; 105(3):237-52. PubMed ID: 10954128 [TBL] [Abstract][Full Text] [Related]
31. Genetic alterations of the ATBF1 gene in gastric cancer. Cho YG; Song JH; Kim CJ; Lee YS; Kim SY; Nam SW; Lee JY; Park WS Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4355-9. PubMed ID: 17671116 [TBL] [Abstract][Full Text] [Related]
32. E-cadherin expression in early gastric carcinoma and correlation with lymph node metastasis. Yi Kim D; Kyoon Joo J; Kyu Park Y; Yeob Ryu S; Soo Kim H; Kyun Noh B; Hwa Lee K; Hyuk Lee J J Surg Oncol; 2007 Oct; 96(5):429-35. PubMed ID: 17786966 [TBL] [Abstract][Full Text] [Related]
33. Expression of PRL-3 phosphatase in human gastric carcinomas: close correlation with invasion and metastasis. Miskad UA; Semba S; Kato H; Yokozaki H Pathobiology; 2004; 71(4):176-84. PubMed ID: 15263806 [TBL] [Abstract][Full Text] [Related]
34. Tissue factor expression is a clinical indicator of lymphatic metastasis and poor prognosis in gastric cancer with intestinal phenotype. Yamashita H; Kitayama J; Ishikawa M; Nagawa H J Surg Oncol; 2007 Mar; 95(4):324-31. PubMed ID: 17066404 [TBL] [Abstract][Full Text] [Related]
35. [Alteration of early growth response 1 expression in gastroenterological cancers and its biological significance]. An J; Guo RF; Zhang L; Geng PL; Lü YY Zhonghua Yi Xue Za Zhi; 2008 May; 88(20):1384-9. PubMed ID: 18953875 [TBL] [Abstract][Full Text] [Related]
36. Expression of ERas oncogene in gastric carcinoma. Kaizaki R; Yashiro M; Shinto O; Yasuda K; Matsuzaki T; Sawada T; Hirakawa K Anticancer Res; 2009 Jun; 29(6):2189-93. PubMed ID: 19528480 [TBL] [Abstract][Full Text] [Related]
37. [Expression of osteopontin mRNA and its clinical significance in gastric cancer]. Sun XJ; Zuo WS; Ma H; Hou WH; Cai SP; Jiang XH Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):292-5. PubMed ID: 15996323 [TBL] [Abstract][Full Text] [Related]
38. [mRNA expression of basic fibroblast growth factor and hepatocyte growth factor in gastric carcinoma and significance thereof]. Ru GQ; Zhao ZS; Tang QL; Xu WJ Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(29):2030-5. PubMed ID: 19080429 [TBL] [Abstract][Full Text] [Related]
39. Down-regulated SPARCL1 is associated with clinical significance in human gastric cancer. Li P; Qian J; Yu G; Chen Y; Liu K; Li J; Wang J J Surg Oncol; 2012 Jan; 105(1):31-7. PubMed ID: 22161898 [TBL] [Abstract][Full Text] [Related]
40. Altered expression of the human base excision repair gene NTH1 in gastric cancer. Goto M; Shinmura K; Igarashi H; Kobayashi M; Konno H; Yamada H; Iwaizumi M; Kageyama S; Tsuneyoshi T; Tsugane S; Sugimura H Carcinogenesis; 2009 Aug; 30(8):1345-52. PubMed ID: 19414504 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]